Omalizumab for the Treatment of Multiple Food AllergiesRobert A. Wood, R. Sharon Chinthrajah, Jennifer Dantzer et al.|New England Journal of Medicine|2024Cited by 298
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut AllergyDavid M. Fleischer, Wayne G. Shreffler, Matthew Greenhawt et al.|JAMA|2019Cited by 271
<em>Deinococcus geothermalis</em>: The Pool of Extreme Radiation Resistance Genes ShrinksKira S. Makarova, Michael J. Daly, Marina V. Omelchenko et al.|Figshare|2016Cited by 249
Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical TrialJ. Andrew Bird, A. Wesley Burks, Jonathan M. Spergel et al.|The Journal of Allergy and Clinical Immunology In Practice|2017Cited by 200
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut AllergyMatthew Greenhawt, Paul Turner, Sayantani Sindher et al.|New England Journal of Medicine|2023Cited by 129